Robert B Greifinger, MD | |
32 Parkway Dr, Dobbs Ferry, NY 10522-3517 | |
(914) 693-9205 | |
Not Available |
Full Name | Robert B Greifinger |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine |
Location | 32 Parkway Dr, Dobbs Ferry, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174617484 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0500X | Preventive Medicine - Preventive Medicine/occupational Environmental Medicine | 112664 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Robert B Greifinger, MD 32 Parkway Dr, Dobbs Ferry, NY 10522-3517 Ph: (914) 693-9205 | Robert B Greifinger, MD 32 Parkway Dr, Dobbs Ferry, NY 10522-3517 Ph: (914) 693-9205 |
News Archive
Nearly 30 percent of U.S. adults with diabetes over the age of 40 are estimated to have diabetic retinopathy, with about 4 percent of this population having vision-threatening retinopathy, according to a study in the August 11 issue of JAMA.
Even with public health measures in place, about two-thirds of Americans think the way the country has handled the pandemic was worse than other countries, an NPR/Ipsos poll finds.
Adding stroke severity to a hospital 30-day mortality model based on claims data for Medicare beneficiaries with acute ischemic stroke was associated with improvement in predicting the risk of death at 30 days and changes in performance ranking regarding mortality for a considerable proportion of hospitals, according to a study in the July 18 issue of JAMA.
Verenium Corporation, a pioneer in the development and commercialization of high-performance enzymes solutions, today announced an agreement with Desmet Ballestra Group s.a., a leading global solutions provider in the field of engineering and delivery of installations and equipment for the edible oil and fats and biodiesel industries, to jointly market the Purifine enzymatic degumming process, which combines Verenium's Purifine PLC enzyme and Desmet Ballestra's engineering services and equipment.
› Verified 9 days ago